ExodusPoint Capital Management, LP

Position in WVE — Wave Life Sciences, Inc.

CIK 1736225 NEW YORK, NY

Position in WVE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,458,728

+$770,063 QoQ

Shares Held

251,072

+166.9% QoQ

Ownership

0.127%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#69

of 237 holders

Holding Since

Jun 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. WVE ranks #48 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,458,728	251,072	+166.9%	Shares	Sole	2026-08-14
2025-09-30	$688,665	94,080	+816.6%	Shares	Sole	2025-11-14
2025-06-30	$66,716	10,264	-89.3%	Shares	Sole	2025-08-13
2025-03-31	$777,845	96,268	+423.7%	Shares	Sole	2025-05-14
2021-09-30	$90,066	18,381	-72.6%	Shares	Sole	2021-11-15
2021-06-30	$447,405	67,178	+82.6%	Shares	Sole	2021-08-16
2020-12-31	$289,560	36,793	-63.9%	Shares	Sole	2021-02-16
2020-09-30	$864,171	101,787	+117.7%	Shares	Sole	2020-11-16
2020-06-30	$486,802	46,763	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.